ADVOCATE. CONNECT. INNOVATE.

Category Archives: Bulletin

CLSA 2018 Industry Report, 14th Annual Pantheon Awards, Upcoming Events, New Members and More!

By: Sara Radcliffe CLSA President & CEO November 29, 2017      New CLSA/PwC 2018 Life Sciences Industry Report Confirms California is #1 Leader in Life Sciences Innovation On Nov. 15, CLSA and PwC unveiled the 2018 California Life Sciences Industry Report with a nationwide webinar and media launch. The 2018 report once again confirms that … Continue reading CLSA 2018 Industry Report, 14th Annual Pantheon Awards, Upcoming Events, New Members and More!

CLSI CARB-X Hosts Intensive Strategy Session for “Powered by CARB-X” Proteus IRC

The CLSI CARB-X team – Heather Shane, Steve Karp, and Amy Xu – hosted Powered by CARB-X company, Proteus IRC, for an intensive strategy session designed to help Proteus transition from a research consortium to a VC-backed entity. The three-day session drew 22 volunteer advisors from 20 different organizations – from as far as Washington, … Continue reading CLSI CARB-X Hosts Intensive Strategy Session for “Powered by CARB-X” Proteus IRC

CLSI Participates in BARDA Industry Days and the One Nucleus Leadership Seminar – Addressing Infectious Disease Challenges

Heather Shane, Executive Director of the California Life Sciences Institute’s (CLSI) CARB-X Accelerator, spoke in November on two occasions about CARB-X and CLSI’s role in helping to move companies that are addressing the problem of Antimicrobial Resistance (AMR) through the product development pipeline. Her first appearance was at BARDA Industry Days in Washington, DC, where … Continue reading CLSI Participates in BARDA Industry Days and the One Nucleus Leadership Seminar – Addressing Infectious Disease Challenges

FAST & Fellows Round Up

November 2017 Read the latest in FAST and Fellows news: Encellin’s (FAST Spring 2017) insulin-releasing implant for Type-1 Diabetes featured on NPR Read More LogicInk (FAST Spring 2017) announced their first product, LogicInk UV, an electronics-free temporary wearable powered by programmable ink Read More Eidos Therapeutics (FAST Spring 2016) initiates Phase 1 trial of AG10, … Continue reading FAST & Fellows Round Up

CARB-X Updates November 2017

Powered by CARB-X company Spero plans for $75M IPO for November 2nd (SPRO) Read More Inhibrx Wins CARB-X Award of up to $6.0M to Accelerate Development of its Novel Antibody, INBRX-111, to Treat Pseudomonas Infections Read More CARB-X backs Integrated Biotherapeutics to accelerate the development of a novel toxoid-based vaccine to prevent drug-resistant MRSA infections … Continue reading CARB-X Updates November 2017

Federal Update: Tax Reform & Impact on the Life Sciences Sector

Congress is currently advancing legislation in both chambers to significantly overhaul the U.S. tax code. Historically, CLSA has focused our tax-related advocacy efforts around: (1) calling for an update and making permanent of the R&D Tax Credit, (2) protecting the Orphan Drug Tax Credit (ODTC), and (3) opposing the creation of and later calling for a repeal of the medical device tax.